SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scripts who wrote (644)9/26/1999 3:23:00 PM
From: Ian@SI  Read Replies (1) of 1321
 
Ed,

I don't know what the dosage would be for Psoriasis.

For AMD during the first year, 3 treatments were generally required spaced at 3 months each. We'll need to await the 2nd year results to find out whether or not that does the trick; or if ongoing treatments are indicated.

QLT appears to have a series of winners on the way. Barrett's Aesophagus has no other reasonable treatment. Psoriasis seems to be generally unresponsive to treatments at this time.

3 Blockbusters for a large cap Drug company would produce significant growth in stock price. For a microcap like QLT, the future is so rosy, you got to wear shades.

:-)

Ian.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News